Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Facility Registration Violations, Refusa

Indian API manufacturer Jagsonpal Pharmaceuticals was issued a Warning Letter by the US FDA in

Qvents
February 22, 2025

USFDA Warning Letter to Akron Formulatio

The USFDA has issued a Warning Letter to Hyderabad-based OTC manufacturer Akron Formulations for critical

Qvents
January 7, 2025

Intas Recall Cisplatin Injection For Imp

Accord Healthcare Inc, US is recalling one lot of Cisplatin injection due to failed impurities.

Qvents
October 14, 2024